Victrelis | search
Click here to view Victrelis news from 60+ newspapers.
Bookmark or Share- Boceprevir (oral route) - Mayo ClinicBoceprevir is used in combination with injectable peginterferon alfa (Pegasys®, Pegintron®) and ribavirin (Copegus®, Rebetol®) to treat chronic hepatitis C infection. These medicines are used in patients with compensated liver disease (including cirrhosis), who have not been treated before or who have received other medicines but did not work well.
- VICTRELIS (boceprevir) 200 mg Capsules - Food and Drug AdministrationVICTRELIS is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with peginterferon alfa and...
- Victrelis: Uses, Dosage, Side Effects & Warnings - Drugs.comWhat is Victrelis? Victrelis is an antiviral medicine that prevents certain viruses from multiplying in your body. Victrelis is used in combination with peginterferon alfa and ribavirin, or with sofosbuvir to treat hepatitis C genotype 1 in adults.
- Victrelis Dosage Guide - Drugs.comThe dose of VICTRELIS is 800 mg (four 200-mg capsules) three times daily (every 7 to 9 hours) with food [a meal or light snack] (see Table 1). Refer to the prescribing information for peginterferon alfa and ribavirin for instructions on dosing.
- Boceprevir - WikipediaBoceprevir (INN, trade name Victrelis) is a protease inhibitor used to treat hepatitis caused by hepatitis C virus (HCV) genotype 1. [2][3] It binds to the HCV nonstructural protein 3 active site. [4] It was initially developed by Schering-Plough, [5] then by Merck after it acquired Schering in 2009. It was approved by the FDA in May 2011. [6] .
More
